Personalis Launches Breast Cancer Study with Yale Cancer Center-February 2024-www.financetom.com

Personalis Launches Breast Cancer Study with Yale Cancer Center

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Personalis Launches Breast Cancer Study with Yale Cancer Center

Sep 10, 2025 2:53 PM

05:20 PM EDT, 09/10/2025 (MT Newswires) -- Personalis ( PSNL ) has partnered with a cancer team from Yale Cancer Center for a clinical trial aimed at enhancing outcomes in patients with breast cancer, it said Wednesday.

The study is funded by the Translational Breast Cancer Research Consortium.

The trial will probe whether ultra-sensitive circulating tumor DNA-guided intervention can prevent metastatic relapse and improve outcomes for patients with HR+/HER2- breast cancer, the company added.

Previous page： Google agrees $36 million fine for anti-competitive deals with Australia telcos Next page： GE Aerospace Unusual Options Activity For June 05

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

GE Aerospace Unusual Options Activity For June 05

Jun 5, 2025

Deep-pocketed investors have adopted a bearish approach towards GE Aerospace , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GE usually suggests something big is about to happen. We gleaned this information from our observations...

Alibaba Gr Hldgs Unusual Options Activity For June 05

Jun 5, 2025

Whales with a lot of money to spend have taken a noticeably bullish stance on Alibaba Gr Hldgs. Looking at options history for Alibaba Gr Hldgs we detected 49 trades. If we consider the specifics of each trade, it is accurate to state that 46% of the investors opened trades with bullish expectations and 40% with bearish. From the overall...

Gilead's HIV Pipeline Gains Traction With Upcoming FDA Decision For HIV-1 Drug

Jun 5, 2025

In February, the U.S. Food and Drug Administration (FDA) accepted Gilead Sciences, Inc.’s New Drug Application (NDA) submissions for lenacapavir — the company’s twice-yearly injectable HIV-1 capsid inhibitor — for the prevention of HIV as pre-exposure prophylaxis (PrEP). What Happened: The FDA will review the applications under priority review and has assigned a Prescription Drug User Fee Act (PDUFA) target...